News
Personalizing Treatment Strategies in Metastatic Hormone-Sensitive Prostate Cancer
9+ hour, 41+ min ago (28+ words) Uro Today Personalizing Treatment Strategies in Metastatic Hormone-Sensitive Prostate Cancer Login to update email address, newsletter preferences and use bookmarks....
Google News
1+ day, 20+ hour ago (16+ words) CORE-008 Cohort B Evaluates Cretostimogene in BCG-Exposed Non-Muscle Invasive Bladder Cancer - Trinity Bivalacqua'Uro Today...
Sun RISe-5 Trial Tests TAR-200 for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer - Sima Porten
1+ week, 1+ day ago (1148+ words) Uro Today...
Phase 2 Thera Pb Trial Evaluates Induction and Maintenance Regimens of 212 Pb-ADVC001 with Adaptive Dosing Across Three Metastatic Prostate Cancer Indications - Anna Karmann
1+ week, 1+ day ago (839+ words) Uro Today...
Rectal Spacers in Prostate Radiotherapy: Balancing Efficacy, Safety, and Patient Experience - Michael Greenberg & Daniel Welchons
1+ week, 2+ day ago (1071+ words) Uro Today Zachary Klaassen: Hi, my name is Zach Klaassen, urologic oncologist at the Georgia Cancer Center in Augusta, Georgia And I'm delighted to be joined on Uro Today by Dr Dan Welchons, who's a urologist at U. S Urology Partners…...
PSMA and Beyond 2026: The Expanding Theranostic Dream: From Hype to Hard Truths
1+ week, 4+ day ago (646+ words) (Uro Today. com)The 2026 PSMA & Beyond conference featured a session on challenges of radioligand therapy and a presentation by Dr. Michael Hofman discussing the expansion of the theranostic dream. Only 8 years ago, in 2018, PSMA PET before and after 177 Lu-PSMA-617 in…...
Large-Scale Analysis Examines Inherited DNA Damage Repair Genes in Advanced Prostate Cancer - Sofie Tolmeijer
2+ week, 5+ day ago (569+ words) Uro Today...
SES AUA 2026: Bladder Cancer Burden from Smoking: Mortality and Disability-Adjusted Life Years in Relation to United States Tobacco Taxation
2+ week, 5+ day ago (581+ words) Uro Today...
State of the Art Lectures in Prostate Cancer from St. Gallen
2+ week, 6+ day ago (32+ words) Uro Today State of the Art Lectures in Prostate Cancer from St. Gallen Login to update email address, newsletter preferences and use bookmarks....
CYTOSHRINK: Evaluating SBRT to the Primary Tumor in De Novo Advanced RCC - Aly-Khan Lalani
3+ week, 17+ hour ago (782+ words) Uro Today Leslie Ballas: Hi, I'm Leslie Ballas I'm a radiation oncologist at Cedars-Sinai in Los Angeles, and I am so happy to be joined by Dr Aly-Khan Lalani, who is an associate professor of oncology at Mc Master University…...